Jilin Province Xidian Pharmaceutical Sci-Tech Development Co had a gross margin of 76.72% for the quarter that ended in Sep. 2024 => Durable competitive advantage
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.5%.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Gross Profit Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Gross Profit Chart
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Gross Profit Distribution in the Drug Manufacturers Industry
Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥191.5 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co had a gross margin of 76.72% for the quarter that ended in Sep. 2024 => Durable competitive advantage
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Gross Profit Related Terms
Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:301130 has been successfully added to your 